Rosemay Herrmann
Family · Bethany Beach, DENPI 1063628071
Payments from drug & device makers
Across 110 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$374
- AbbVie$363
- Lilly USA, LLC$353
- Novartis$266
- Johnson & Johnson$202
- Radius Health, Inc.$139
- plus $645 from 18 others
What the payments were for
- Food & beverage$2,342100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 18 | $374 |
| AbbVie | 17 | $363 |
| Lilly USA, LLC | 17 | $353 |
| Novartis | 14 | $266 |
| Johnson & Johnson | 7 | $202 |
| Radius Health, Inc. | 6 | $139 |
| UCB, Inc. | 5 | $107 |
| Mallinckrodt Hospital Products Inc. | 2 | $61 |
| Genentech USA, Inc. | 2 | $56 |
| AstraZeneca(2 entities) | 3 | $54 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $37 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
| Merck | 1 | $32 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $29 |
| Exact Sciences | 1 | $25 |
| Organon | 2 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Novo Nordisk | 1 | $16 |
| Bioventus LLC | 1 | $14 |
How this compares
$2,342 in reported general payments places this provider in the 80th percentile of 523 family providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 27 | $857 |
| Methylprednisolone | 26 | $249 |
| Atorvastatin Calcium | 23 | $246 |
| Omeprazole | 13 | $160 |
| CefuroximeCefuroxime Axetil | 12 | $136 |
| Famotidine | 16 | $133 |
| Metformin Hcl | 17 | $124 |
| Azithromycin | 18 | $86 |
| Amoxicillin | 12 | $83 |
| Paroxetine Hcl | 13 | $77 |
| Gabapentin | 18 | $76 |
| Amlodipine Besylate | 20 | $75 |
| Losartan Potassium | 13 | $65 |
Paid to pharmacies, not to this prescriber.
Other family in Bethany Beach
- Brandi GreggeMiddletown$110K
- Tracy EstesWilmington$59K
- Kathy GallagherNewark$53K
- Jodie DelesioNewark$50K
- Abby AllenGeorgetown$43K
- Taylor HodgesLewes$33K
- Jodi KahanWilmington$21K
- Valerie HarrisonBridgeville$15K
- Kathleen GustafsonBear$15K
- Elizabeth Sharp-AsiyoWilmington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.